ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 106 filers reported holding ATHIRA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $859,495 | -31.5% | 425,492 | 0.0% | 0.01% | -63.2% |
| Q2 2023 | $1,255,200 | +18.0% | 425,492 | 0.0% | 0.02% | +11.8% |
| Q1 2023 | $1,063,731 | -87.0% | 425,492 | -88.3% | 0.02% | -75.7% |
| Q4 2022 | $8,182,650 | -24.1% | 3,631,080 | 0.0% | 0.07% | -27.8% |
| Q3 2022 | $10,784,154 | +109.4% | 3,631,080 | +115.0% | 0.10% | -14.2% |
| Q2 2022 | $5,150,963 | -77.0% | 1,688,840 | -2.4% | 0.11% | -78.4% |
| Q1 2022 | $22,390,000 | +19.1% | 1,729,540 | +19.9% | 0.52% | +11.5% |
| Q4 2021 | $18,792,000 | +74.7% | 1,442,247 | +25.8% | 0.47% | +49.0% |
| Q3 2021 | $10,754,000 | +58.7% | 1,146,447 | +73.3% | 0.31% | +54.7% |
| Q2 2021 | $6,775,000 | -26.3% | 661,612 | +32.5% | 0.20% | -34.7% |
| Q1 2021 | $9,189,000 | +227.7% | 499,416 | +509.9% | 0.31% | +170.4% |
| Q4 2020 | $2,804,000 | +79.3% | 81,883 | -3.3% | 0.12% | -32.4% |
| Q3 2020 | $1,564,000 | – | 84,699 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $351,351 | 0.48% |
| Perceptive Advisors | 4,797,278 | $14,632,000 | 0.46% |
| Ikarian Capital, LLC | 784,200 | $2,393,000 | 0.44% |
| Bristlecone Advisors, LLC | 700,926 | $2,138,000 | 0.26% |
| Altium Capital Management LP | 200,100 | $610,000 | 0.24% |
| RA Capital Management | 1,878,000 | $5,728,000 | 0.15% |
| Logos Global Management LP | 220,000 | $671,000 | 0.12% |
| PATHSTONE FAMILY OFFICE, LLC | 1,688,840 | $5,150,963 | 0.11% |
| Ikarian Capital, LLC | 199,500 | $609,000 | 0.11% |
| SG3 Management, LLC | 206,000 | $628,000 | 0.07% |